These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 35000793)

  • 1. Long-term outcomes after NeuroCOVID: A 6-month follow-up study on 60 patients.
    Chaumont H; Meppiel E; Roze E; Tressières B; de Broucker T; Lannuzel A;
    Rev Neurol (Paris); 2022; 178(1-2):137-143. PubMed ID: 35000793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Global Incidence of Neurological Manifestations Among Patients Hospitalized With COVID-19-A Report for the GCS-NeuroCOVID Consortium and the ENERGY Consortium.
    Chou SH; Beghi E; Helbok R; Moro E; Sampson J; Altamirano V; Mainali S; Bassetti C; Suarez JI; McNett M;
    JAMA Netw Open; 2021 May; 4(5):e2112131. PubMed ID: 33974053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Global Consortium Study of Neurological Dysfunction in COVID-19 (GCS-NeuroCOVID): Development of Case Report Forms for Global Use.
    McNett M; Fink EL; Schober M; Mainali S; Helbok R; Robertson CL; Mejia-Mantilla J; Kurtz P; Righy C; Roa JD; Villamizar-Rosales C; Altamirano V; Frontera JA; Maldonado N; Menon D; Suarez J; Chou SHY
    Neurocrit Care; 2020 Dec; 33(3):793-828. PubMed ID: 32948987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Global Consortium Study of Neurological Dysfunction in COVID-19 (GCS-NeuroCOVID): Study Design and Rationale.
    Frontera J; Mainali S; Fink EL; Robertson CL; Schober M; Ziai W; Menon D; Kochanek PM; Suarez JI; Helbok R; McNett M; Chou SH;
    Neurocrit Care; 2020 Aug; 33(1):25-34. PubMed ID: 32445105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emerging potential mechanisms and predispositions to the neurological manifestations of COVID-19.
    Jesuthasan A; Massey F; Manji H; Zandi MS; Wiethoff S
    J Neurol Sci; 2021 Sep; 428():117608. PubMed ID: 34391037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurological presentations of COVID-19: Findings from the Spanish Society of Neurology neuroCOVID-19 registry.
    García-Azorín D; Abildúa MJA; Aguirre MEE; Fernández SF; Moncó JCG; Guijarro-Castro C; Platas MG; Delgado FR; Andrés JML; Ezpeleta D;
    J Neurol Sci; 2021 Apr; 423():117283. PubMed ID: 33636661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An Italian multicenter retrospective-prospective observational study on neurological manifestations of COVID-19 (NEUROCOVID).
    Ferrarese C; Silani V; Priori A; Galimberti S; Agostoni E; Monaco S; Padovani A; Tedeschi G;
    Neurol Sci; 2020 Jun; 41(6):1355-1359. PubMed ID: 32430621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Markers of blood-brain barrier disruption increase early and persistently in COVID-19 patients with neurological manifestations.
    Bonetto V; Pasetto L; Lisi I; Carbonara M; Zangari R; Ferrari E; Punzi V; Luotti S; Bottino N; Biagianti B; Moglia C; Fuda G; Gualtierotti R; Blasi F; Canetta C; Montano N; Tettamanti M; Camera G; Grimoldi M; Negro G; Rifino N; Calvo A; Brambilla P; Biroli F; Bandera A; Nobili A; Stocchetti N; Sessa M; Zanier ER
    Front Immunol; 2022; 13():1070379. PubMed ID: 36591311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuro-COVID frequency and short-term outcome in the Northern Portuguese population.
    Oliveira V; Seabra M; Rodrigues R; Carvalho V; Mendes M; Pereira D; Caldeiras C; Martins B; Silva R; Azevedo A; Lima MJ; Monteiro C; Varela R; Malheiro S; Abreu M; Azevedo E; Leal Loureiro J; Tedim Cruz V; Silva MR; Magalhães R; Silva C; Maia LF; Correia M
    Eur J Neurol; 2021 Oct; 28(10):3360-3368. PubMed ID: 33884707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prospective study of long-term outcomes among hospitalized COVID-19 patients with and without neurological complications.
    Frontera JA; Yang D; Lewis A; Patel P; Medicherla C; Arena V; Fang T; Andino A; Snyder T; Madhavan M; Gratch D; Fuchs B; Dessy A; Canizares M; Jauregui R; Thomas B; Bauman K; Olivera A; Bhagat D; Sonson M; Park G; Stainman R; Sunwoo B; Talmasov D; Tamimi M; Zhu Y; Rosenthal J; Dygert L; Ristic M; Ishii H; Valdes E; Omari M; Gurin L; Huang J; Czeisler BM; Kahn DE; Zhou T; Lin J; Lord AS; Melmed K; Meropol S; Troxel AB; Petkova E; Wisniewski T; Balcer L; Morrison C; Yaghi S; Galetta S
    J Neurol Sci; 2021 Jul; 426():117486. PubMed ID: 34000678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebrospinal fluid biomarkers in SARS-CoV-2 patients with acute neurological syndromes.
    Chaumont H; Kaczorowski F; San-Galli A; Michel PP; Tressières B; Roze E; Quadrio I; Lannuzel A
    Rev Neurol (Paris); 2023 Mar; 179(3):208-217. PubMed ID: 36610823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Addressing Long COVID Sequelae and Neurocovid: Neuropsychological Scenarios and Neuroimaging Findings.
    Celeghin A; Stanziano M; Palermo S
    Adv Exp Med Biol; 2024; 1457():143-164. PubMed ID: 39283425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurological manifestations associated with COVID-19: a review and a call for action.
    Leonardi M; Padovani A; McArthur JC
    J Neurol; 2020 Jun; 267(6):1573-1576. PubMed ID: 32436101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NeuroCOVID: critical review of neuropsychiatric manifestations of SARS-CoV-2 infection.
    Oliveira R; Sotero FD; Teodoro T
    Ir J Med Sci; 2021 May; 190(2):851-852. PubMed ID: 32901422
    [No Abstract]   [Full Text] [Related]  

  • 15. Neurological outcome and quality of life 3 months after COVID-19: A prospective observational cohort study.
    Rass V; Beer R; Schiefecker AJ; Kofler M; Lindner A; Mahlknecht P; Heim B; Limmert V; Sahanic S; Pizzini A; Sonnweber T; Tancevski I; Scherfler C; Zamarian L; Bellmann-Weiler R; Weiss G; Djamshidian A; Kiechl S; Seppi K; Loeffler-Ragg J; Pfausler B; Helbok R
    Eur J Neurol; 2021 Oct; 28(10):3348-3359. PubMed ID: 33682276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spectrum of hospitalized NeuroCOVID diagnoses from a tertiary care neurology centre in Eastern India.
    Bhansali S; Bagrodia V; Choudhury S; Rahman S; Golder M; Tiwari M; Kumar H
    J Clin Neurosci; 2021 Nov; 93():96-102. PubMed ID: 34656269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurological symptoms, manifestations, and complications associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease 19 (COVID-19).
    Harapan BN; Yoo HJ
    J Neurol; 2021 Sep; 268(9):3059-3071. PubMed ID: 33486564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurological Sequelae of COVID-19.
    Ahmad SJ; Feigen CM; Vazquez JP; Kobets AJ; Altschul DJ
    J Integr Neurosci; 2022 Apr; 21(3):77. PubMed ID: 35633158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COVID-19 and neurologic manifestations: a synthesis from the child neurologist's corner.
    Valderas C; Méndez G; Echeverría A; Suarez N; Julio K; Sandoval F
    World J Pediatr; 2022 Jun; 18(6):373-382. PubMed ID: 35476245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome predictors of post-COVID conditions in the European Academy of Neurology COVID-19 registry.
    Leone MA; Helbok R; Bianchi E; Yasuda CL; Konti M; Ramankulov D; Lolich M; Lovrencic-Huzjan A; Kovács T; Armon C; Cotelli MS; Cavallieri F; Grosu O; Kiteva-Trenchevska G; Rodriguez-Leyva I; Boldingh M; Brola W; Maia LF; de Seabra MML; Davidescu EI; Popescu BO; Kopishinskaia S; Bassetti CLA; Moro E;
    J Neurol; 2024 Jun; 271(6):3153-3168. PubMed ID: 38436682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.